S 2074 116th Congress Senate Commerce Administrative law and regulatory procedures Drug therapy Drug trafficking and controlled substances Drug, alcohol, tobacco use Federal preemption Government information and archives Health care coverage and access Health personnel Licensing and registrations Prescription drugs State and local government operations

Mainstreaming Addiction Treatment Act of 2019

Introduced: July 10, 2019 Introduced by: Hassan, Margaret Wood Democratic · New Hampshire See on congress.gov

Everywhere this bill has been 2 steps

Introduced

In committee

Reported out

Passed House

Passed Senate

To President

Became law

Jul 10, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Jul 10, 2019

Introduced in Senate

Plain-English summary Congressional Research Service

Mainstreaming Addiction Treatment Act of 2019

This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).

Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity.

The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.

What's happening now July 10, 2019

Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees of jurisdiction 1